Therapeutic options in the treatment of tinea capitis

Referencs

• HAY RJ: Endemic scalp ringworm: an object lesson in control of a common fungal infection. Carr: Opin. Infect. Dis. (2001) 14:121–122.
   PubMedGoogle Scholar
• LOBATO MN, VUGIA DJ, FRIEDEN IJ: Tinea capitis in California children: a population-based study of a growing epidemic. Pediatrics (1997) 99:551–554.
   PubMed Web of Science ®Google Scholar
• FIGUEROA JI, HAWRANEK T, ABRAHA A, HAY RJ: Tinea capitis in south-western Ethiopia: a study of risk factors for infection and carriage. Int. J. Dermatol (1997) 36:661–666.
   PubMed Web of Science ®Google Scholar
• HAY RJ, CLAYTON YM, DE SILVA N, MIDGLEY G, ROSSOR E: Tinea capitis in south-east London-a new pattern of infection with public health implications. Br: J. Dermatol (1996) 135(6):955–958.
   PubMedGoogle Scholar
• CHILD FJ, FULLER LC, HIGGINS EM, DU VIVIER AW: A study of the spectrum of skin disease occurring in a black population in south-east London.Br: J. Dermatol (1999) 141:512–517.
   PubMedGoogle Scholar
• FRIEDEN IJ: Tinea capitis: asymptomatic carriage of infection. Pediatr. Infect. Dis. (1999) 18:186–190.
   Google Scholar
• POMERANZ AJ, SABNIS SS, MCGRATH GJ, ESTERLY NB: Asymptomatic dermatophyte carriers in the households of children with tinea capitis. Arch. Pediatr. Adolesc. Med. (1999) 153:483–486.
   PubMedGoogle Scholar
• SILVERBERG NB, WEINBERG JM, DELEO VA: Tinea capitis: focus on African American women. Am. Acad. Dermatol (2002) 46:S120–S124.
   Google Scholar
• FRIEDLANDER SF, PICKERING B, CUNNINGHAM BB, GIBBS NE EICHENFIELD LF: Use of the cotton swab method in diagnosing Tinea capitis. Pediatrics (1999) 104(2 Pt 1):276–279.
   Google Scholar
• MITCHELL F, YAMAMOTO RS, WEISBURGER JH: Griseofulvin: immunosuppressive action. Proc. Soc. Exp. Biol. Med. (1973) 143:165–167.
   PubMed Web of Science ®Google Scholar
• KROWCHUK DP, LUCKY AW, PRIMMER SI, MCGUIRE J: Current status of the identification and management of tinea capitis. Pediatrics (1983) 72:625–631.
   PubMedGoogle Scholar
• SHARPE BA et al.: Investigation into theefficacy of conventional dose griseofulvin for treatment of tinea capitis 2000 Poster presentation #3, Society for Pediatric Dermatology Annual Meeting, July 12–15, (2000) Santa Fe, New Mexico.
   Google Scholar
• AMERICAN ACADEMY OFPEDIATRICS: 2003 Red Book: Report of the Committee on Infectious Diseases (26th edit) Elk Grove Village, IL, USA (2003).
   Google Scholar
• NYAWALO JO, BWIRE M: Single dose and intermittent griseofulvin regimens in the treatment of tinea capitis in Kenya. Mycoses (1988) 31:229–234.
   PubMedGoogle Scholar
• GAN VN, PETRUSKA M,GINSBURG CM: Epidemiology and treatment of tinea capitis: ketoconazole versus griseofulvin. Pediatr. Infect. Dis. (1987) 6:46–49.
   Google Scholar
• TANZ RR, HERBERT AA, ESTERLY NB: Treating tinea capitis: should ketoconazole replace griseofulvin? Pediatr. (1988) 112:987–991.
   Google Scholar
• LOPEZ- GOMEZS, DEL PALACIO A, VAN CUTSEM J et al.: Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int. J. Dermatol (1994) 33:743–747.
   Google Scholar
• HAROON TS, HUSSAIN I, AMAN S et al: A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis. Dermatol Treat. (1995) 6:167–169.
   Web of Science ®Google Scholar
• GUPTA AK, ADAM P, DLOVA N et al: Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr. Dermatol (2001) 18:433–438.
   PubMed Web of Science ®Google Scholar
• FULLER LC, SMITH CH, CERIO R et al.: A randomized comparison of 4 weeks of terbinafine versus 8 weeks of griseofulvin for the treatment of tinea capitis.Br. J. Dermatol (2001) 144:321–327.
   Google Scholar
• LIPOZENCIC J, SKERLEV M, OROFINO-COSTA R et al.: A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. Br. Dermatol (2002) 146:816–823.
   PubMed Web of Science ®Google Scholar
• JENSEN JC: Clinical pharmacokinetics of terbinafine (Lamisil). Clin. Exp. Dermatol (1989) 14:110–113.
   PubMed Web of Science ®Google Scholar
• BALFOUR JA, FAULDS D: Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs (1992) 43:259–284.
   Google Scholar
• FAERGEMANN J, ZEHENDER H, JONES T, MAIBACH I: Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat.Acta Derm. Venereol (1991) 71:322–326.
   PubMed Web of Science ®Google Scholar
• FAERGEMANN J, ZEHENDER H, MILLERIOUX L: Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin. Exp. Dermatol (1994) 19:121–126.
   PubMed Web of Science ®Google Scholar
• BAUDRAZ-ROSSELET F, MONOD M, JACCOUD S, FRENK E: Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species. Br. J. Dermatol (1996) 135:1011–1012.
   PubMedGoogle Scholar
• CACERES-RIOS H, RUEDA M, BALLONA R, BUSTAMANTE B: Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. Am. Acad. Dermatol (2000) 42(1 Pt 1):80–84.
   Google Scholar
• RADEMAKER M, HAVILL S: Griseofulvin and terbinafine in the treatment of tinea capitis in children. NZ Med J. (1998) 111:55–57.
   PubMedGoogle Scholar
• FILHO ST, CUCE LC, FOSS NT, MARQUES SA, SANTAMARIA JR: Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. J. Ear: Acad. Dermatol Venereol (1998) 11:141–146.
   Google Scholar
• HAROON TS, HUSSAIN I, AMAN S et al.: A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. Br. J. Dermatol (1996) 135:86–88.
   PubMed Web of Science ®Google Scholar
• KULLAVANIJAYA P,REANGCHAINAM S, UNGPAKORN R: Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. Am. Acad. Dermatol (1997) 37(2 Pt 1):272–273.
   Google Scholar
• GUPTA AK, ADAM P: Terbinafine pulse therapy is effective in tinea capitis. Pediatr. Dermatol (1998) 15:56–58.
   PubMedGoogle Scholar
• HAY RJ: Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions. J. Am. Acad. Dermatol (1993) 29:S50–S54.
   Google Scholar
• AGUILAR C, MUELLER KK: Reversibleagranulocytosis associated with oral terbinafine in a pediatric patient. j. Am. Acad. Dermatol (2001) 45:632–634.
   PubMedGoogle Scholar
• ABDEL-RAHMAN SM,GOTSCHALL RR, KAUFFMAN RE, LEEDERJS, KEARNS GL: Investigation of terbinafine as a CYP2D6 inhibitor in vivo. Clin. Pharmacy]. Ther. (1999) 65:465–472.
   PubMed Web of Science ®Google Scholar
• CALLEN JP, HUGHES AP, KULP-SHORTEN C: Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.Arch. Dermatol (2001) 137:1196–1198.
   PubMedGoogle Scholar
• FRIEDLANDER SF, ALY R,KRAFCHIK B et al.: TINEA CAPITIS STUDY GROUP: Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. Pediatrics (2002) 109:602–607.
   Google Scholar
• SILM H, KARELSON M: Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis. Ear: Acad. Dermatol Venereol(2002) 16:228–230.
   PubMed Web of Science ®Google Scholar
• GRANT SM, CLISSOLD SP: Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.Drugs (1989) 37:310–344.
   Google Scholar
• FRIEDLANDER SF: The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.Pediatr. Infect. Dis. J. (1999) 18:205–210.
   PubMed Web of Science ®Google Scholar
• JAHANGIR M, HUSSAIN I,UL HASAN M, HAROON TS: A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. Br. J. Dermatol (1998) 139:672–674.
   PubMedGoogle Scholar
• LEGENDRE R, ESOLA-MACRE J: Itraconazole in the treatment of tineacapitis. Am. Acad. Dermatol (1990) 23:559–560.
   PubMed Web of Science ®Google Scholar
• GUPTA AK, HOFSTADER SL, SUMMERBELL RC et al.: Treatment of tinea capitis with itraconazole capsule pulse therapy. J. Am. Acad. Dermatol (1998) 39:216–219.
   PubMedGoogle Scholar
• GUPTA AK, SOLOMON RS, ADAM P: Itraconazole oral solution for the treatment of tinea capitis. Br. .1. Dermatol (1998) 139:104–106.
   PubMed Web of Science ®Google Scholar
• ABDEL-RAHMAN SM, POWELL DA, NAHATA MC: Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. Am. Acad. Dermatol (1998) 38:443–436.
   PubMedGoogle Scholar
• GUPTA AK, GINTER G: Itraconazole is effective in the treatment of tinea capitis caused by Microsporum canis.Pediatr. Dermatol (2001) 18:519–22.
   PubMed Web of Science ®Google Scholar
• WILDFEUER A, FAERGEMANN J, LAUFEN H et al.: Bioavailability of fluconazole in the skin after oral medication. Mycoses (1994) 37:127–130.
   PubMed Web of Science ®Google Scholar
• SOLOMON BA, COLLINS R, SHARIVIA R et al.: Fluconazole for the treatment of tinea capitis in children.J. Ain. Acad. Dermatol (1997) 37:274–275.
   PubMed Web of Science ®Google Scholar
• GUPTA AK, ADAM P, HOFSTADER SL et al.: Intermittent short duration therapy with fluconazole is effective for tinea capitis.Br: J. Dermatol (1999) 141:304–306.
   PubMed Web of Science ®Google Scholar
• GUPTA AK, DLOVA N, TAB ORDA P et al.: Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br. .1. Dermatol (2000) 142:965–968.
   Google Scholar
• VALARI M, IORDANIDOU A, RAFTOPOULOU A, PANGALIS A:Fluconazole in the treatment of pediatric tinea capitis caused by Microsporum canis.Drugs Exp. Clin. Res. (2002) 28:161–164.
   PubMedGoogle Scholar
• ALLEN HB, HONIG PJ, LEYDEN JJ, MCGINLEY KJ: Selenium sulphide: adjunctive therapy for tinea capitis.Pediatrics (1982) 69:81–83.
   PubMed Web of Science ®Google Scholar
• GIBBENS TG, MURRAY MM,BAKER RC: Comparison of 1% and 2.5% selenium sulphide in treatment of tinea capitis. Arch. Pediatr. Adolesc. Med. (1995) 149:808–811.
   Google Scholar
• GREER DL: Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int. J. Dermatol (2000) 39:302–304.
   PubMedGoogle Scholar
• HUSSAIN I, MUZAFFAR F, RASHID T, AHMAD TJ, JAHANGIR M,HAROON TS: A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone versus griseofulvin alone. Med. Myra (1999) 37:97–99.
   Google Scholar
• HONIG PJ, CAPUTO GL, LEYDEN JJ,MCGINLEY K, SELBST SM, MCGRAVEY AR: Treatment of kerions. Pediatr. Dermatol (1994) 11:69–71.
   PubMedGoogle Scholar
• MOHRENSCHLAGER M, SCHNOPP C et al.: Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Br. J. Dermatol (2000) 143:1011–1015.
   PubMedGoogle Scholar